Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income from Continuing Operations: 2009-2024

Historic Income from Continuing Operations for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $130.0 million.

  • Select Medical Holdings' Income from Continuing Operations rose 703.56% to $44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.3 million, marking a year-over-year decrease of 2328.92%. This contributed to the annual value of $130.0 million for FY2024, which is 1766.62% up from last year.
  • Per Select Medical Holdings' latest filing, its Income from Continuing Operations stood at $130.0 million for FY2024, which was up 1766.62% from $110.5 million recorded in FY2023.
  • Select Medical Holdings' 5-year Income from Continuing Operations high stood at $499.9 million for FY2021, and its period low was $18.5 million during FY2022.
  • In the last 5 years, Select Medical Holdings' Income from Continuing Operations had a median value of $130.0 million in 2024 and averaged $220.7 million.
  • Per our database at Business Quant, Select Medical Holdings' Income from Continuing Operations tumbled by 9629.06% in 2022 and then soared by 49569.16% in 2023.
  • Over the past 5 years, Select Medical Holdings' Income from Continuing Operations (Annual) stood at $344.6 million in 2020, then soared by 45.08% to $499.9 million in 2021, then crashed by 96.29% to $18.5 million in 2022, then soared by 495.69% to $110.5 million in 2023, then grew by 17.67% to $130.0 million in 2024.
  • Its last three reported values are $130.0 million in FY2024, $110.5 million for FY2023, and $18.5 million during FY2022.